Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Isolated rapid eye movement (REM) sleep behavior disorder (iRBD) is a prodromal stage of Lewy-type synucleinopathies (LTS), which can present either with an initial predominant parkinsonism (Parkinson’s disease (PD)) or dementia (dementia with Lewy bodies (DLB)). To provide insights into the underlying pathogenic mechanisms, the lipoprotein and pro...
Alternative Titles
Full title
Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bec3a6f30fef41dabe057654c4d8d8bc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bec3a6f30fef41dabe057654c4d8d8bc
Other Identifiers
ISSN
2373-8057
E-ISSN
2373-8057
DOI
10.1038/s41531-021-00184-9
